oxeladin and Glioma
oxeladin has been researched along with Glioma in 1 studies
oxeladin: RN given refers to parent cpd; structure
Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Lee, SJ | 1 |
| Yeom, SY | 1 |
| Lee, JY | 1 |
| Park, C | 1 |
Other Studies
1 other study available for oxeladin and Glioma
| Article | Year |
|---|---|
Application of the antitussive agents oxelaidin and butamirate as anti-glioma agents.
Topics: Animals; Antineoplastic Agents; Antitussive Agents; Apoptosis; Binding Sites; Cell Line, Tumor; Cell | 2021 |